Evidence map›Paper›PMID 36520312›Full record

ArticleSub-cellular biochemistry2023

Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity.

Sarah J Backe, Mark R Woodford, Elham Ahanin, Rebecca A Sager, Dimitra Bourboulia, Mehdi Mollapour

Open access · greenAbstract read
In one paragraph

Article in Sub-cellular biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sarah J BackeDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Mark R WoodfordDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Elham AhaninDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Rebecca A SagerDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Dimitra BourbouliaDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Mehdi MollapourDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA. mollapom@upstate.edu.
SUNY Upstate Medical University · US

Funding

Regulatory mechanisms of the Hsp90 chaperone machinery.R35GM139584 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2021 to 2025
$2.2M
Crosstalk between post-translational regulations of the FNIP co-chaperones and their impact on Hsp90 chaperone function and drug bindingR01GM124256 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2017 to 2020
$1.3M
Regulation of the extracellular HSP90 chaperone machineryR01GM139932 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI BOURBOULIA, DIMITRA · 2021 to 2024
$1.3M
NIGMS NIH HHS R01 GM124256NIGMS NIH HHS R01 GM139932NIGMS NIH HHS R35 GM139584
6 · The paper itself

Abstract

Posttranslational modifications (PTMs) regulate myriad cellular processes by modulating protein function and protein-protein interaction. Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone whose activity is responsible for the stabilization and maturation of more than 300 client proteins. Hsp90 is a substrate for numerous PTMs, which have diverse effects on Hsp90 function. Interestingly, many Hsp90 clients are enzymes that catalyze PTM, demonstrating one of the several modes of regulation of Hsp90 activity. Approximately 25 co-chaperone regulatory proteins of Hsp90 impact structural rearrangements, ATP hydrolysis, and client interaction, representing a second layer of influence on Hsp90 activity. A growing body of literature has also established that PTM of these co-chaperones fine-tune their activity toward Hsp90; however, many of the identified PTMs remain uncharacterized. Given the critical role of Hsp90 in supporting signaling in cancer, clinical evaluation of Hsp90 inhibitors is an area of great interest. Interestingly, differential PTM and co-chaperone interaction have been shown to impact Hsp90 binding to its inhibitors. Therefore, understanding these layers of Hsp90 regulation will provide a more complete understanding of the chaperone code, facilitating the development of new biomarkers and combination therapies.

Indexed as

HSP90 Heat-Shock ProteinsNeoplasmsAdenosine TriphosphateHumansMolecular ChaperonesProtein Processing, Post-TranslationalAdenosine TriphosphateHSP90 Heat-Shock ProteinsMolecular ChaperonesChaperoneChaperone codeCo-chaperoneHsp90Hsp90 inhibitorsPhosphorylationPTM

Identifiers

PMID36520312
PMCPMC10077965
OpenAlexW4311774732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.